MaaT Pharma to Seek EMA Re-Examination for Xervyteg After CHMP Rejection
LYON, France, June 26, 2026 MaaT Pharma announced plans to request a re-examination of the European Medicines Agency (EMA)...
CHRONOS study
Advertisement
MaaT Pharma CHRONOS Data Reveals Poor aGvHD Survival
LYON, France, April 1, 2026 MaaT Pharma has announced the publication of CHRONOS study data in the peer-reviewed Bone...
Advertisement
